We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$170B
1-Year Est. Return
46.21%
This Fund
S&P 500
This Quarter
Est. Return
+7.69%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+586.77%
AUM
$38.5B
AUM Growth
+$4.01B
(+12%)
Cap. Flow
+$2.13B
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
2,400
New
147
Increased
1,057
Reduced
1,017
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$295M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$119M |
| 3 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$110M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$103M |
| 5 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$95.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$182M |
| 2 |
Edgewell Personal Care
EPC
|
+$107M |
| 3 |
Hain Celestial
HAIN
|
+$92.5M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$86.9M |
| 5 |
PDLI
PDL BioPharma, Inc.
PDLI
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.25% |
| 2 | Miscellaneous | 16.83% |
| 3 | Technology | 11.31% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akamai
AKAM
$16B
| $165M | 0.43% |
3,127,154
+1,137,288
| +57% | +$69.9M |
|
27
Nektar Therapeutics
NKTR
$2.47B
| $162M | 0.42% |
639,941
-52,371
| -8% | -$10.8M |
|
28
Illumina
ILMN
$31.1B
| $157M | 0.41% |
841,937
-14,052
| -2% | -$2.27M |
|
29
Gilead Sciences
GILD
$181B
| $155M | 0.4% |
1,528,312
-507,304
| -25% | -$52.8M |
|
30
Sysco
SYY
$39.1B
| $152M | 0.39% |
3,702,249
+2,017,160
| +120% | +$82.7M |
|
|
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
| $152M | 0.39% |
3,380,705
-265,720
| -7% | -$11.1M |
|
|
CTXS
32
DELISTED
Citrix Systems Inc
CTXS
| $150M | 0.39% |
2,496,194
+374,570
| +18% | +$23M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $150M | 0.39% |
784,231
-26,908
| -3% | -$4.7M |
|
|
WBA
34
DELISTED
Walgreens Boots Alliance
WBA
| $149M | 0.39% |
1,748,505
+427,888
| +32% | +$36.3M |
|
|
RAI
35
DELISTED
Reynolds American Inc
RAI
| $146M | 0.38% |
3,170,389
+529,039
| +20% | +$24.5M |
|
36
Ionis Pharmaceuticals
IONS
$9.33B
| $144M | 0.37% |
2,327,482
+74,981
| +3% | +$4.05M |
|
|
JNPR
37
DELISTED
Juniper Networks
JNPR
| $143M | 0.37% |
5,192,816
+1,051,606
| +25% | +$31.1M |
|
|
TWTR
38
DELISTED
Twitter, Inc.
TWTR
| $140M | 0.36% |
6,029,270
+1,657,458
| +38% | +$44.2M |
|
39
Archer Daniels Midland
ADM
$41.5B
| $139M | 0.36% |
3,802,210
+617,772
| +19% | +$24.7M |
|
|
DYAX
40
DELISTED
DYAX CORPORATION
DYAX
| $139M | 0.36% |
+3,705,078
| New | +$119M |
|
41
First Trust Switzerland AlphaDEX Fund
FSZ
$36.5M
| $138M | 0.36% |
3,448,846
-61,647
| -2% | -$2.43M |
|
42
Constellation Brands
STZ
$20.8B
| $138M | 0.36% |
968,516
-29,131
| -3% | -$4.01M |
|
43
First Trust United Kingdom AlphaDEX Fund
FKU
$36.4M
| $138M | 0.36% |
3,432,177
-61,338
| -2% | -$2.52M |
|
44
Alkermes
ALKS
$7.62B
| $134M | 0.35% |
1,693,076
-155,007
| -8% | -$10.9M |
|
45
First Trust Germany AlphaDEX Fund
FGM
$100M
| $134M | 0.35% |
3,710,799
-66,319
| -2% | -$2.37M |
|
46
TripAdvisor
TRIP
$1.07B
| $134M | 0.35% |
1,575,253
+111,466
| +8% | +$9M |
|
47
Altria Group
MO
$113B
| $130M | 0.34% |
2,238,593
+1,001,116
| +81% | +$58M |
|
48
CVS Health
CVS
$123B
| $130M | 0.34% |
1,326,560
-153,371
| -10% | -$15M |
|
49
Bio-Techne
TECH
$11.3B
| $128M | 0.33% |
5,710,036
+686,212
| +14% | +$15.6M |
|
50
Amgen
AMGN
$211B
| $128M | 0.33% |
790,576
-130,282
| -14% | -$20.5M |
|
Similar funds
First Trust Advisors's Q4 2015 Portfolio in Review
As of Q4 2015, First Trust Advisors held 2,400 positions worth $38.5B, up 12% from $34.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
First Trust Advisors deployed $2.13B of net new capital in Q4 2015, opening 147 new positions and adding to 1,057 existing holdings. Its largest new stake was Alphabet (Google) Class A: 7,974,380 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $182M trimmed.
- First Trust Advisors's largest Q4 2015 buy was Alphabet (Google) Class A: 7,974,380 shares worth $310M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q4 2015, an estimated $110M increase.
- First Trust Advisors's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $182M.
- First Trust Advisors fully exited Edgewell Personal Care in Q4 2015, selling an estimated $107M.
- First Trust Advisors's ten largest holdings make up 18% of its $38.5B portfolio in Q4 2015.
- First Trust Advisors opened 147 new positions and closed 171 in Q4 2015.
- First Trust Advisors's portfolio value rose 12% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q4 2015, filed 3 Feb 2016.